ARCHIVES

DOD To Reimburse Care On Clinical Trials In Three-Year Deal

This article is from The Cancer Letter archive.

Vol. 22 No. 06 | February 9, 1996

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

Cancer Act 25th Year: cancer Mortality Rate Began decline In 1990s, NCI, ACS Studies Find

November 22, 1996

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

In Brief: AMY ABERNETHY Was Named Chair of a New CancerLinQ Advisory Committee Within the Institute for Quality, An Affiliate Of The American Society of Clinical Oncology.

November 22, 2013